Breaking News

Cambrex Opens New Stability Storage Facility in Belgium

Expands capacity for environmentally controlled stability storage services to the pharmaceutical, medical device and life sciences industries.

Cambrex, a global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, announced that their stability storage business, Q1 Scientific, has opened a new 20,000 sq. ft. cGMP facility in Belgium, expanding its capacity for environmentally controlled stability storage services to the pharmaceutical, medical device and life sciences industries across Europe. Strategically located in the Liège re...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters